Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « C. D. Marsden »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
C. D. Holmes < C. D. Marsden < C. D. Parkinson  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000647 (1998) U. K. Rinne [Finlande] ; F. Bracco [Italie] ; C. Chouza [Uruguay] ; E. Dupont [Danemark] ; O. Gershanik [Argentine] ; J. F. Marti Masso [Espagne] ; J. L. Montastruc [France] ; C. D. Marsden [Royaume-Uni]Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial
000659 (1997) V. Plante-Bordeneuve [France] ; D. Taussig [France] ; F. Thomas [France] ; G. Said [France] ; N. W. Wood [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. E. Harding [Royaume-Uni]Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease : Evidence for association of a DRD2 allele
000661 (1997) U. K. Rinne [Finlande] ; F. Bracco [Italie] ; C. Chouza [Uruguay] ; E. Dupont [Danemark] ; O. Gershanik [Argentine] ; J. F. Marti Masso [Espagne] ; J. L. Montastruc [France] ; C. D. Marsden [Royaume-Uni] ; A. Dubini [Italie] ; N. Orlando [Italie] ; R. Grimaldi [Italie]Cabergoline in the treatment of early Parkinson's disease : Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa
000708 (1991) D. T. Dexter [Royaume-Uni] ; A. Carayon [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. R. Wells [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; A. J. Lees [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
000717 (1990) R. Raisman-Vozari [France] ; J.-A. Girault [États-Unis] ; S. Moussaoui [France] ; C. Feuerstein [France] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Yves Agid [France]Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
000718 (1990) D. T. Dexter [Royaume-Uni] ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Yves Agid [France] ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. MarsdenDecreased ferritin levels in brain in Parkinson's disease
000721 (1988) H. Taquet [France] ; M. Nomoto [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; F. Javoy-Agid [Royaume-Uni] ; A. Mauborgne [France] ; J. J. Benoliel [France] ; C. D. Marsden [Royaume-Uni] ; J. C. Legrand [France] ; Yves Agid [France] ; M. Hamon [France] ; F. Cesselin [France]Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment

List of associated KwdEn.i

Nombre de
documents		Descripteur
5Human
5Parkinson disease
2Cabergoline
2Chemotherapy
2Comparative study
2Degenerative disease
2Double blind study
2Early
2Ergot derivatives
2Exploration
2Humans
2Nervous system diseases
2Proteins
2Treatment
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1Aged
1Aged, 80 and over
1Alleles
1Amine oxidase (flavin-containing)
1Animal
1Animals
1Antiparkinson agent
1Autopsy
1Biochemical analysis
1Blood
1Brain
1Callitrichinae
1Carrier Proteins (genetics)
1Carrier protein
1Cerebrospinal fluid
1Controlled therapeutic trial
1Corpus Striatum (metabolism)
1Corpus Striatum (physiopathology)
1Corpus striatum
1D2 Dopamine receptor
1DARPP-32
1Dopamine
1Dopamine (metabolism)
1Dopamine (physiology)
1Dopamine Plasma Membrane Transport Proteins
1Dopamine agonist
1Dopamine and cAMP-Regulated Phosphoprotein 32
1Dopaminergic lesion
1Dopaminergic pathway
1Etiopathogenesis
1Experimental disease
1Family Health
1Female
1Ferritin
1Gene
1Inorganic element
1Iron
1Levodopa
1Locus niger
1Male
1Membrane Glycoproteins
1Membrane Transport Proteins
1Monoamine Oxidase (genetics)
1Multicenter study
1Nerve Tissue Proteins (genetics)
1Nerve Tissue Proteins (metabolism)
1Parkinson
1Parkinson Disease (genetics)
1Parkinson Disease, Secondary (metabolism)
1Pathogenesis
1Phosphoprotein
1Phosphoproteins
1Phosphorylation
1Polymerase chain reaction
1Polymorphism, Genetic
1Prevention
1Randomization
1Rats
1Receptors, Dopamine D2 (genetics)
1Striatum
1Substantia Nigra (physiology)
1Toxicity
1Tyrosine hydroxylase

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "C. D. Marsden" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "C. D. Marsden" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    C. D. Marsden
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024